好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Safety and Tolerability, but Lack of Efficacy of Tolperisone (AV650) in Multiple Sclerosis Patients with Spasticity: A Double-Blind, Placebo-Controlled, Randomized Trial of Tolperisone Administered Orally Three Times a Day
MS and Related Diseases
(-)
133
Authors/Disclosures
Robert M. Elfont, MD, PhD (Strategic Clinical Development, LLC) No disclosure on file
No disclosure on file
No disclosure on file
Raymond Chavez No disclosure on file
No disclosure on file
No disclosure on file
Kirk W. Johnson, PhD (XOMA Corp) No disclosure on file
Drew S. Jones, MD, MPH (Baxter Health Care Corp) No disclosure on file
Glenn Morrison, PhD (Annexon Biosciences) Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has stock in Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file